Freddy Abnousi MD, MBA, MSc

VP Health Technologies at META

Dr. Abnousi is VP of Health Technology at Meta and a practicing Interventional Cardiologist. He additionally serves as Professor Adjunct at Stanford University School of Medicine, and Assistant Professor Adjunct at Yale University School of Medicine. He has previously led innovative healthcare efforts at companies such as McKinsey and Google, and has served as Founder and CMO of CorDynamix Inc., an interventional heart failure company. He completed Fellowships in Cardiovascular Medicine and Interventional Cardiology, as well as Residency in Internal Medicine at Stanford University Medical Center. He was previously a resident surgeon at the University of California, San Francisco. He completed his MD at Stanford University School of Medicine, MBA from Oxford University, and MSc in Health Policy, Planning, & Financing from the London School of Economics.

Dr. Howard Podolsky

CEO at Johns Hopkins Aramco Healthcare

Dr. Howard Podolsky, CEO of JHAH, combines medicine, law & business expertise with 25+ years’ leadership to guide Johns Hopkins Aramco Healthcare transformation in alignment with Saudi Arabia’s Vision 2030.

Roberta Marinelli

President and General Manager, META Hub at Eli Lilly and Company

Roberta Marinelli is an accomplished senior executive with over two decades of international experience in the pharmaceutical and healthcare industries. She currently serves as President and General Manager for Lilly’s META region, based in Dubai.

Eng. Mohanned Alrasheed

CEO at Lean Business Services

Mohanned Al Rasheed, founding CEO of Lean Business Services, is shaping a better future for health in Saudi Arabia. Through pioneering innovations and bold vision, he is leading transformative changes that are redefining care nationwide.

Eng. Nart Mamser

Chief Executive Officer at Altakhassusi Alliance Medical

Healthcare leader and innovator. As CEO of Altakassusi Alliance Medical, Nart Mamser transforms radiology services, shaping the future of healthcare across Saudi Arabia and the wider region.

HE Hosams Abu Meri

Minister of Health at Ministry of Health, Latvia

Hosams Abu Meri has served as Minister for Health of the Republic of Latvia since September 2023. He has been actively involved in Latvian politics since 2011, when he became Advisor to the Minister of the Interior. He became Parliamentary Secretary in the Ministry of Welfare in 2016–2017, Chairman of the “Unity” faction in the parliament in 2017–2018, and served as Advisor to the Prime Minister for Integration Affairs from 2019 to 2022. Abu Meri is a distinguished gastroenterologist, specializing in endoscopy. He qualified as a medical doctor at the Medical Academy of Latvia, before gaining diplomas in internal medicine and gastroenterology from the University of Latvia.

Dr. Fouziyah Aljarallah

Chief Executive Officer at Hayat National Hospitals

Dr. Fouziyah Aljarallah, Group CEO of Hayat National Hospitals since 2006, leads a 2,700+ bed network, driving transformative growth and positioning the group as a premier healthcare provider in Saudi Arabia and the wider region.

Dr. Mina Elisha Bekheet

CEO & Managing Partner at Panacea

Dr Mina Bekheet is a serial entrepreneur and venture capitalist, Founder & CEO of Panacea—backing 400+ life-science and health-tech start-ups worth £2bn+. He holds an Oxford PhD and advises governments and global funds on life-science strategy.

Mr. Michel Poulain

Co-founder | Emeritus Professor | Senior Researcher at Original Blue Zones Hotspot | Université Catholique de Louvain

Award-winning scientist and co-discoverer of the Blue Zones, redefined global longevity research. His pioneering work validating the world’s longest-living populations set the gold standard for aging science and is featured in Netflix’s Live to 100: Secrets of the Blue Zones.

Dr. Fatih Mehmet Gul

Chief Executive Officer at The View Hospital

Recognized by Forbes as one of the Top 50 Healthcare Leaders​
Led the launch of Fakeeh University Hospital the Middle East's first environmentally friendly, LEED-certified university hospital​
Founded CSR Middle East in 2005. He is one of the most active supporters of King Charles’s Terra Carta initiative

Dr. Aaron Gerber

President, Diversified Businesses and Senior Vice President at Mass General Brigham

Aaron is the strategic force behind Mass General Brigham's diversified healthcare portfolio, leveraging his physician background and entrepreneurial success to transform care delivery models. His leadership spans founding multiple healthcare ventures and orchestrating $110M+ business portfolios that bridge clinical innovation with sustainable growth strategies.

Aashima Gupta

Global Director of Healthcare Solutions at Google

Aashima Gupta is a Global visionary driving AI-first transformation across the healthcare and life sciences ecosystem. Aashima has been named one of the Five Most Influential Women in Health IT by HIMSS and Top 30 Healthcare Leaders in Healthcare.

Dr. Helmut Schuehsler

CEO & Chairman at TVM Capital Healthcare

Dr. Schuehsler is a pioneering investor and operator, shaping the global healthcare landscape. As Chairman & CEO of TVM Capital Healthcare, he has directed over $2B in global healthcare investments, building hospitals and care networks across the Middle East and Asia and establishing himself as one of the foremost voices in healthcare private equity.

Dr. Mark Davies

Chief Health Officer at IBM

Mr. Barton Buxton

President & CEO, Healthcare Management Group at McLaren Healthcare Group

President & CEO of McLaren Health Management Group, part of McLaren Health Care, one of Michigan’s largest integrated health systems with 12 hospitals, 250+ sites of care, and over 113,000 network providers extending into Indiana. Under his leadership, McLaren has pioneered telehealth transformation, seamlessly expanding access to rural and urban communities alike, and driven major investments including a $35 million Oakland–Oxford medical campus. With the nationally renowned Karmanos Cancer Institute anchoring the system, Buxton has been at the forefront of advancing population health, innovation, and care delivery at scale.

HRH Prince Khaled bin Alwaleed bin Talal Al Saud

President | Founder & CEO at Saudi Sports for All Federation (SFA) | KBW Ventures

Prosun Niyogi

WW Vice President & Managing Director Middle East & Africa at Johnson & Johnson

Prof. Kwan Chee Allen Chan

Associate Vice President and Professor of Chemical Pathology at The Chinese University of Hong Kong

Professor Allen K.C. Chan is a globally acclaimed clinician-scientist and biotech innovator, co-inventor of over 120 groundbreaking inventions in noninvasive prenatal testing and cancer detection, with a staggering portfolio of over 1,500 patents granted worldwide; his work, adopted in over 90 countries, has transformed global diagnostics and earned him recognition among Nature Biotechnology’s Top 20 Translational Researchers.

Dr. Cother Hajat

Public Health Professor and Advisor at Real World Health

Global public health leader and architect of award-winning NCD strategies, with 30 years’ impact across the UN, WHO, WEF, and GCC governments. She bridges policy, precision health, and innovation to drive systemic change in how populations prevent and manage chronic disease.

Dr. Elisabeth Roider, MD, PhD, MBA

Founding Partner at Maximon

Physician-scientist and longevity innovator where she leads the development of science-backed longevity ventures at Maximon. Recipient of the Margot and Erich Goldschmidt & Peter René Jacobson Foundation Award for excellence in medical research. Patent co-inventor: Method for enhancing skin pigmentation via redox modulation in melanocytes Published in high-impact journals on melanoma, NAD+ longevity strategies, and COVID-related diagnostic delays

Dr. George Margelis

Chief Technology Advisor at Ageing Australia

Medical doctor with strong experience in software development and marketing. Interest in improving quality and delivery of healthcare utilising information technology.
Currently involved in development and implementation of innovative healthcare solutions delivered over the internet.

Prof. Siow Ming Lee

Professor and Consultant Medical Oncologist at University College London Hospitals/UCL

Professor Siow Ming Lee serves as Professor of Medical Oncology at University College London (UCL) and Consultant Medical Oncologist at University College London Hospitals (UCLH). He specializes in lung cancer treatment and research, having designed and led numerous groundbreaking clinical trials over more than two decades.
An internationally recognized authority in his field, Professor Lee was honored with the British Thoracic Oncology Group's Lifetime Achievement Award for his exceptional contributions to lung cancer research. His work has influenced treatment paradigms and improved outcomes for lung cancer patients, with particular expertise in immunotherapy, targeted treatments, and DNA repair pathways.

Dr. Katharina Grimm

FIFA Medical Lead at Federation Internationale de Football Associations FIFA

Directs all medical services planning and implementation at FIFA tournaments globally, focusing on athlete health and performance. serves on the Union of European Football Associations’ Therapeutic Use Exemption Committee and is a member of the Board of Directors at the Center for Sports Equity at Stanford.

Nicola Blackwood

Member of the House of Lords and Chair of Genomics England

The first female MP for Oxford and former Health Minister & Minister of Innovation, now leads as Chair of Genomics England while serving on the boards of Oxford University Innovation and biotechnology pioneer BioNTech. As a member of the House of Lords, she continues to shape science and innovation policy through her distinguished leadership roles.

Dr. David Rhew

Global Chief Medical Officer & VP of Healthcare at Microsoft

Dr. David is the architect behind Microsoft's global health strategy, leading efforts that have transformed digital healthcare across 190+ countries. Twice named one of Modern Healthcare's 100 Most Influential People in Healthcare, he holds six U.S. technology patents in electronic health records and clinical AI and has been a driving force behind some of the most impactful public-private partnerships in health innovation today.

Dr. Matthew Shaw

CEO at Great Ormond Street Hospital for Children NHS Foundation Trust

Matthew is the CEO of Great Ormond Street Hospital, ranked the No.1 children's hospital in Europe and 6th globally where he leads one of the world's most iconic pediatric institutions, driving breakthroughs in rare disease, complex surgery, and child health innovation.